{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:49:28Z","timestamp":1763830168527},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/s11938-003-0050-5","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T15:13:20Z","timestamp":1180883600000},"page":"481-491","source":"Crossref","is-referenced-by-count":12,"title":["Treatment of ascites"],"prefix":"10.1007","volume":"6","author":[{"given":"Jayanta","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"50_CR1","first-page":"990","volume-title":"Diseases of the Liver","author":"BA Runyon","year":"1993","unstructured":"Runyon BA: Ascites. In Diseases of the Liver. Edited by Schiff L, Schiff ER. Philadephia: Lippincott; 1993:990\u20131015."},{"key":"50_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM199402033300508","volume":"330","author":"BA Runyon","year":"1994","unstructured":"Runyon BA: Care of patients with ascites. N Engl J Med 1994, 330:337\u2013342.","journal-title":"N Engl J Med"},{"key":"50_CR3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","volume":"7","author":"P Gines","year":"1987","unstructured":"Gines P, Quintero E, Arroyo V, et al.: Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987, 7:122\u2013128.","journal-title":"Hepatology"},{"key":"50_CR4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, et al.: Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988, 8:1151\u20131157.","journal-title":"Hepatology"},{"key":"50_CR5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1089-3261(05)70118-5","volume":"4","author":"A Cardenas","year":"2000","unstructured":"Cardenas A, Bataller R, Arroyo V: Mechanisms of ascites formation. Clin Liver Dis 2000, 4:447\u2013465.","journal-title":"Clin Liver Dis"},{"key":"50_CR6","first-page":"411","volume-title":"Ascites and Renal Dysfunction in Liver Disease.","author":"P Gines","year":"1999","unstructured":"Gines P, Schrier RW: The arterial vasodilation hypothesis of ascites formation in cirrhosis. In Ascites and Renal Dysfunction in Liver Disease. Edited by Arroyo V, Gines P, Rodes J, Schrier RW. Malden, MA: Blackwell Science; 1999:411\u2013427."},{"key":"50_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","volume":"339","author":"PY Martin","year":"1998","unstructured":"Martin PY, Gines P, Schrier RW: Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998, 339:533\u2013541.","journal-title":"N Engl J Med"},{"key":"50_CR8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM196010132631505","volume":"263","author":"TB Reynolds","year":"1960","unstructured":"Reynolds TB, Geller HM, Kuzma OT, Redeker AG: Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. N Engl J Med 1960, 263:734\u2013739.","journal-title":"N Engl J Med"},{"key":"50_CR9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.510270139","volume":"27","author":"BA Runyon","year":"1998","unstructured":"Runyon BA: Management of adult patients with ascites caused by cirrhosis. Hepatology 1998, 27:264\u2013272.","journal-title":"Hepatology"},{"issue":"suppl 1","key":"50_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004836-198100031-00016","volume":"3","author":"MR Fogel","year":"1981","unstructured":"Fogel MR, Sawhney VK, Neal EA, et al.: Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol 1981, (3 suppl 1):73\u201380.","journal-title":"J Clin Gastroenterol"},{"key":"50_CR11","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/0016-5085(92)91730-R","volume":"102","author":"I Sungaila","year":"1992","unstructured":"Sungaila I, Bartle WR, Walker SE, et al.: Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology 1992, 102:1680\u20131685.","journal-title":"Gastroenterology"},{"key":"50_CR12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2165\/00003495-199243030-00003","volume":"43","author":"P Gines","year":"1992","unstructured":"Gines P, Arrovo V, Rodes J: Pharmacotherapy of ascites associated with cirrhosis. Drugs 1992, 43:316\u2013332.","journal-title":"Drugs"},{"key":"50_CR13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.1840190113","volume":"19","author":"P Angeli","year":"1994","unstructured":"Angeli P, Dalla PM, De Bei E, et al.: Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites. Hepatology 1994, 19:72\u201379.","journal-title":"Hepatology"},{"key":"50_CR14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1572-0241.2000.01980.x","volume":"95","author":"CP Li","year":"2000","unstructured":"Li CP, Lee FY, Hwang SJ, et al.: Treatment of mastalgia with tamoxifen in male patients with liver cirrhosis: a randomized crossover study. Am J Gastroenterol 2000, 95:1051\u20131055.","journal-title":"Am J Gastroenterol"},{"key":"50_CR15","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM198912143212403","volume":"321","author":"MM Stanley","year":"1989","unstructured":"Stanley MM, Ochi S, Lee KK, et al.: Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. N Engl J Med 1989, 321:1632\u20131638.","journal-title":"N Engl J Med"},{"key":"50_CR16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","volume":"94","author":"P Gines","year":"1988","unstructured":"Gines P, Tito L, Arroyo V, et al.: Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988, 94:1493\u20131502.","journal-title":"Gastroenterology"},{"key":"50_CR17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","volume":"111","author":"A Gines","year":"1996","unstructured":"Gines A, Fernandez-Esparrach G, Monescillo A, et al.: Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996, 111:1002\u20131010.","journal-title":"Gastroenterology"},{"key":"50_CR18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1537-2995.1991.31291142949.x","volume":"31","author":"PA McVay","year":"1991","unstructured":"McVay PA, Toy PT: Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991, 31:164\u2013171.","journal-title":"Transfusion"},{"key":"50_CR19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","volume":"342","author":"M Rossle","year":"2000","unstructured":"Rossle M, Ochs A, Gulberg V, et al.: A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000, 342:1701\u20131707. Important study.","journal-title":"N Engl J Med"},{"key":"50_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","volume":"25","author":"D Lebrec","year":"1996","unstructured":"Lebrec D, Giuily N, Hadengue A, et al.: Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996, 25:135\u2013144.","journal-title":"J Hepatol"},{"key":"50_CR21","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","volume":"123","author":"P Gines","year":"2002","unstructured":"Gines P, Uriz J, Calahorra B, et al.: TIPS versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002, 123:1839\u20131847. Important study.","journal-title":"Gastroenterology"},{"key":"50_CR22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","volume":"124","author":"AJ Sanyal","year":"2003","unstructured":"Sanyal AJ, Genning C, Reddy KR, et al.: The North American study for the treatment of refractory ascites. Gastroenterology 2003, 124:634\u2013641. Important study.","journal-title":"Gastroenterology"},{"key":"50_CR23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, et al.: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000, 31:864\u2013871.","journal-title":"Hepatology"},{"key":"50_CR24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","volume":"325","author":"P Gines","year":"1991","unstructured":"Gines P, Arroyo V, Vargas V, et al.: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991, 325:829\u2013835.","journal-title":"N Engl J Med"},{"key":"50_CR25","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/BF01296625","volume":"36","author":"BA Runyon","year":"1991","unstructured":"Runyon BA, Akriviadis EA, Sattler FR, Cohen J: Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis. Dig Dis Sci 1991, 36:1782\u20131786.","journal-title":"Dig Dis Sci"},{"key":"50_CR26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1053\/jhep.2003.50120","volume":"37","author":"J Castellote","year":"2003","unstructured":"Castellote J, Lopez C, Gornals J, et al.: Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology 2003, 37:893\u2013896.","journal-title":"Hepatology"},{"key":"50_CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/514940","volume":"27","author":"J Such","year":"1998","unstructured":"Such J, Runyon BA: Spontaneous bacterial peritonitis. Clin Infect Dis 1998, 27:669\u2013674.","journal-title":"Clin Infect Dis"},{"key":"50_CR28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3810\/pgm.2001.02.854","volume":"109","author":"N Garcia Jr","year":"2001","unstructured":"Garcia N Jr, Sanyal AJ: Minimizing ascites. Complication of cirrhosis signals clinical deterioration. Postgrad Med 2001, 109:91\u2013103.","journal-title":"Postgrad Med"},{"key":"50_CR29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0016-5085(96)70069-0","volume":"111","author":"M Navasa","year":"1996","unstructured":"Navasa M, Follo A, Llovet JM, et al.: Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996, 111:1011\u20131017.","journal-title":"Gastroenterology"},{"key":"50_CR30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0168-8278(00)80221-4","volume":"32","author":"E Ricart","year":"2000","unstructured":"Ricart E, Soriano G, Novella MT, et al.: Amoxicillinclavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 2000, 32:596\u2013602.","journal-title":"J Hepatol"},{"key":"50_CR31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hep.1840090313","volume":"9","author":"TL Fong","year":"1989","unstructured":"Fong TL, Akriviadis EA, Runyon BA, Reynolds TB: Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis. Hepatology 1989, 9:423\u2013426.","journal-title":"Hepatology"},{"key":"50_CR32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/0016-5085(91)90221-6","volume":"100","author":"BA Runyon","year":"1991","unstructured":"Runyon BA, McHutchison JG, Antillon MR, et al.: Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 1991, 100:1737\u20131742.","journal-title":"Gastroenterology"},{"key":"50_CR33","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","volume":"20","author":"A Follo","year":"1994","unstructured":"Follo A, Llovet JM, Navasa M, et al.: Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994, 20:1495\u20131501.","journal-title":"Hepatology"},{"key":"50_CR34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, et al.: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 341:403\u2013409.","journal-title":"N Engl J Med"},{"key":"50_CR35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJM199908053410610","volume":"341","author":"NM Bass","year":"1999","unstructured":"Bass NM: Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis. N Engl J Med 1999, 341:443\u2013444.","journal-title":"N Engl J Med"},{"key":"50_CR36","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/j.1572-0241.1999.01662.x","volume":"94","author":"RE Brand","year":"1999","unstructured":"Brand RE: Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis: is it worth the cost? Am J Gastroenterol 1999, 94:3404\u20130.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"50_CR37","first-page":"1171","volume":"22","author":"A Rolachon","year":"1995","unstructured":"Rolachon A, Cordier L, Bacq Y, et al.: Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 1995, 22(4 Pt 1):1171\u20131174.","journal-title":"Hepatology"},{"key":"50_CR38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7326\/0003-4819-122-8-199504150-00007","volume":"122","author":"N Singh","year":"1995","unstructured":"Singh N, Gayowski T, Yu VL, Wagener MM: Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 1995, 122:595\u2013598.","journal-title":"Ann Intern Med"},{"issue":"4","key":"50_CR39","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","volume":"12","author":"P Gines","year":"1990","unstructured":"Gines P, Rimola A, Planas R, et al.: Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990, 12(4 Pt 1):716\u2013724.","journal-title":"Hepatology"},{"key":"50_CR40","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510290608","volume":"29","author":"B Bernard","year":"1999","unstructured":"Bernard B, Grange JD, Khac EN, et al.: Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999, 29:1655\u20131661.","journal-title":"Hepatology"},{"key":"50_CR41","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.1840160318","volume":"16","author":"J Llach","year":"1992","unstructured":"Llach J, Rimola A, Navasa M, et al.: Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992, 16:724\u2013727.","journal-title":"Hepatology"},{"key":"50_CR42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/gast.2001.22580","volume":"120","author":"G Garcia-Tsao","year":"2001","unstructured":"Garcia-Tsao G: Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001, 120:726\u2013748.","journal-title":"Gastroenterology"},{"key":"50_CR43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(98)80061-5","volume":"29","author":"JD Grange","year":"1998","unstructured":"Grange JD, Roulot D, Pelletier G, et al.: Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol 1998, 29:430\u2013436.","journal-title":"J Hepatol"},{"key":"50_CR44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00365520150218110","volume":"36","author":"CS Chang","year":"2001","unstructured":"Chang CS, Yang SS, Kao CH, et al.: Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis. Scand J Gastroenterol 2001, 36:92\u201396.","journal-title":"Scand J Gastroenterol"},{"issue":"supp 1","key":"50_CR45","first-page":"A","volume":"120","author":"BJ Sandhu","year":"2001","unstructured":"Sandhu BJ, Jain R, Singh J, et al.: bination of norfloxacin and cisapride in prevention of SBP in high risk patients: a new approach [abstract] Gastroenterology 2001, 120 (supp 1):A-376.","journal-title":"Gastroenterology"},{"key":"50_CR46","unstructured":"Unbiased Prescription Drug Comparison Shopper. June 26, 2001."},{"key":"50_CR47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gut.46.5.588","volume":"46","author":"P Gines","year":"2000","unstructured":"Gines P, Arroyo V: Is there still a need for albumin infusions to treat patients with liver disease? Gut 2000, 46:588\u2013590.","journal-title":"Gut"},{"key":"50_CR48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM198501173120307","volume":"312","author":"DS Milliner","year":"1985","unstructured":"Milliner DS, Shinaberger JH, Shuman P, Coburn JW: Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. N Engl J Med 1985, 312:165\u2013167.","journal-title":"N Engl J Med"},{"key":"50_CR49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(83)90014-4","volume":"2","author":"MR Wills","year":"1983","unstructured":"Wills MR, Savory J: Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet 1983, 2:29\u201334.","journal-title":"Lancet"},{"key":"50_CR50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF01468502","volume":"52","author":"J Ring","year":"1974","unstructured":"Ring J, Seifert J, Lob G, et al.: Human serum albumin incompatibility: clinical and immunological investigations. Klin Wochenschr 1974, 52:595\u2013598.","journal-title":"Klin Wochenschr"},{"key":"50_CR51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0016-5085(90)91303-N","volume":"98","author":"L Tito","year":"1990","unstructured":"Tito L, Gines P, Arroyo V, et al.: Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology 1990, 98:146\u2013151.","journal-title":"Gastroenterology"},{"key":"50_CR52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.510230105","volume":"23","author":"AJ Sanyal","year":"1996","unstructured":"Sanyal AJ, Freedman AM, Purdum PP, et al.: The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996, 23:32\u201339.","journal-title":"Hepatology"},{"key":"50_CR53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0016-5085(98)70371-3","volume":"115","author":"AJ Sanyal","year":"1998","unstructured":"Sanyal AJ, Reddy KR: Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998, 115:110\u2013115.","journal-title":"Gastroenterology"},{"key":"50_CR54","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM200006083422311","volume":"342","author":"JR Lake","year":"2000","unstructured":"Lake JR: The role of transjugular shunting in patients with ascites. N Engl J Med 2000, 342:1745\u20131747.","journal-title":"N Engl J Med"},{"key":"50_CR55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000171147","volume":"4","author":"PJ Campbell","year":"1986","unstructured":"Campbell PJ, Greig PD, Blendis LM: The LeVeen shunt: mechanisms of action, indications and contraindications to its use. Dig Dis 1986, 4:178\u2013192.","journal-title":"Dig Dis"},{"key":"50_CR56","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0016-5085(92)91514-5","volume":"103","author":"G Soriano","year":"1992","unstructured":"Soriano G, Guarner C, Tomas A, et al.: Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992, 103:1267\u20131272.","journal-title":"Gastroenterology"},{"key":"50_CR57","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/gast.1997.v113.pm9322524","volume":"113","author":"J Inadomi","year":"1997","unstructured":"Inadomi J, Sonnenberg A: Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology 1997, 113:1289\u20131294.","journal-title":"Gastroenterology"},{"key":"50_CR58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"KP Moore","year":"2003","unstructured":"Moore KP, Wong F, Gines P, et al.: The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003, 38:258\u2013266.","journal-title":"Hepatology"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-003-0050-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-003-0050-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-003-0050-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:59Z","timestamp":1559422619000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-003-0050-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1007\/s11938-003-0050-5","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}